Get the Weekly Intelligence Brief — top committee picks every Sunday.

ACA vs ALLE

Arcosa, Inc. vs Allegion — AI-powered side-by-side comparison
ACA
Arcosa, Inc.
65
Buy
VS
ALLE
Allegion
70
Buy
MetricACAALLE
AI Score 65 70
Price $144.97 $168.41
P/E Ratio 14.49× 21.99×
ROE 7.9% 31.1%
Revenue Growth YoY
Gross Margin 23.0% 44.8%
Debt / Equity 0.48× 0.96×
Dividend Yield 0.1% 1.3%
RSI (14) 51.0 68.5
Beta 1.071 0.845
Expected Upside +8.8%

AI Committee View

Current Innellis committee reasoning for ACA versus ALLE.
ALLE leads by 5 points.

ALLE scores 70/100 (Buy) versus ACA at 65/100 (Buy).

ACA Committee View
83% agreement
6 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is news sentiment is negative (-0.33 across 3 articles, 14d). The committee is constructive but not yet at full conviction.

Bull Case
  • P/E of 14.5 is inexpensive for the broad market — Value
  • ROE of 18.1% shows genuine earnings power backing the valuation — Value
  • EPS growing 431.7% YoY — Growth
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
  • News sentiment is negative (-0.33 across 3 articles, 14d) — News
ALLE Committee View
80% agreement
5 analysts

The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is bollinger bandwidth of 32.4% signals elevated volatility. The committee is constructive but not yet at full conviction.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • Bollinger bandwidth of 32.4% signals elevated volatility — Risk
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ACA Full Analysis ALLE Full Analysis